International Clinical Trial: Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome

Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07778810) titled 'Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome' on Aug. 18.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Johns Hopkins University

Condition: Sturge - Weber Syndrome (SWS)

Intervention: Drug: Epidiolex 100 mg/mL Oral Solution

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: August 2026

Target Sample Size: 10

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07778810

Disclaimer: ...